| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $167.9M | +145.3% |
| SG&A Expense | $49.0M | +99.4% |
| Operating Income | -$216.9M | -133.2% |
| Pre-tax Income | -$182.1M | -116.9% |
| Income Tax | $18K | — |
| Net Income | -$182.1M | -116.9% |
| EPS (Basic) | -$3.30 | +1.8% |
| EPS (Diluted) | -$3.30 | +1.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $141.8M | +19.8% |
| Short-term Investments | $378.9M | +36.7% |
| Current Assets | $529.7M | +33.0% |
| Total Assets | $754.0M | +87.8% |
| Current Liabilities | $28.6M | +38.9% |
| Total Liabilities | $37.2M | +72.9% |
| Stockholders' Equity | $716.8M | +88.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$171.2M | -129.0% |
| Capital Expenditures | $1.2M | +589.8% |
| Investing Cash Flow | -$300.5M | -9.7% |
| Financing Cash Flow | $495.1M | +57.0% |
| Free Cash Flow | -$172.3M | -130.0% |